Skip to main content
SpringerLink
Log in

Premalignant Lesions: Combination Treatments in Cryosurgery

  • Chapter
  • First Online:
Cryosurgery

Abstract

Cryosurgery is the most commonly used single or multiple procedural individual therapies. As a field therapy, it has proven effective but its use much less common. The current approach when dealing with sun-damaged skin is to combine individual therapies with field therapies. These combinations give better therapeutic results than either treatment used separately. Some common combinations are with retinoics, 5-fluorouracil, diclofenac sodium 3 %, and ingenol mebutate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Salasche SJ. Epidemiology of actinic keratosis and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4–7.

    Article  PubMed  CAS  Google Scholar 

  2. The Lewin Group Inc. for the Society of Investigative Dermatology and The American Academy of Dermatology Association. The burden of skin diseases. Available at: http://www.lewin.com/~/media/Lewin/Site_Sections/Publications/april2005skindisease.pdf. Accessed 15 Dec 2013.

  3. Fenske NA, Spencer J, Adam F. Actinic keratoses: past, present and future. J Drugs Dermatol. 2010;9(5 Suppl ODAC Conf Pt 1):s45–9.

    PubMed  Google Scholar 

  4. Goldberg LH, Mamelak AJ. Review of actinic keratosis. Part I: etiology, epidemiology and clinical presentation. J Drugs Dermatol. 2010;9(9):1125–32.

    PubMed  Google Scholar 

  5. Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169(3):502–18.

    Article  PubMed  CAS  Google Scholar 

  6. Gupta AK, Inniss K, Wainwright R, Chow M, Cooper E. Interventions for actinic keratoses (Protocol). Cochrane Database Syst Rev. 2003, Issue 4. Art. No.: CD004415. doi: 10.1002/14651858.CD004415.

  7. Stockfleth E. The paradigm shift in treating actinic keratosis: a comprehensive strategy. J Drugs Dermatol. 2012;11(12):1462–7.

    PubMed  CAS  Google Scholar 

  8. Terushkin V, Braga JC, Dusza SW, Scope A, Busam K, Marghoob AA, Gill M, Halpern AC. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms. Dermatol Surg. 2010;36(10):1514–20.

    Article  PubMed  CAS  Google Scholar 

  9. Huerta-Brogeras M, Olmos O, Borbujo J, Hernández-Núñez A, Castaño E, Romero-Maté A, Martínez-Sánchez D, Martínez-Morán C. Validation of dermoscopy as a real-time noninvasive diagnostic imaging technique for actinic keratosis. Arch Dermatol. 2012;148(10):1159–64.

    Article  PubMed  Google Scholar 

  10. Zalaudek I, Giacomel J, Argenziano G, Hofmann-Wellenhof R, Micantonio T, Di Stefani A, Oliviero M, Rabinovitz H, Soyer HP, Peris K. Dermoscopy of facial nonpigmented actinic keratosis. Br J Dermatol. 2006;155(5):951–6.

    Article  PubMed  CAS  Google Scholar 

  11. Cuellar F, Vilalta A, Puig S, Palou J, Salerni G. New dermoscopic pattern in actinic keratosis and related conditions. Arch Dermatol. 2009;145(6):732.

    Article  PubMed  Google Scholar 

  12. Zalaudek I, Giacomel J, Schmid K, Bondino S, Rosendahl C, Cavicchini S, Tourlaki A, Gasparini S, Bourne P, Keir J, Kittler H, Eibenschutz L, Catricalà C, Argenziano G. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. J Am Acad Dermatol. 2012;66(4):589–97.

    Article  PubMed  Google Scholar 

  13. Stockfleth E, Zwingers T, Willers C. Recurrence rates and patient assessed outcomes of 0.5 % 5-fluorouracil in combination with salicylic acid treating actinic keratoses. Eur J Dermatol. 2012;22(3):370–4.

    PubMed  CAS  Google Scholar 

  14. Ianhez M, Fleury Jr LF, Miot HA, Bagatin E. Retinoids for prevention and treatment of actinic keratosis. An Bras Dermatol. 2013;88(4):585–93.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Thai KE, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L, Murrell D, Anderson C, Weightman W, Reid C, Watson A, Foley P. A prospective study of the use of cryosurgery for the treatment of actinic keratosis. Int J Dermatol. 2004;43(9):687–92.

    Article  PubMed  Google Scholar 

  16. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, Thai KE, Murrell D, Weightman W, Anderson C, Reid C, Watson A, Foley P. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. 2003;14(2):99–106.

    Article  PubMed  CAS  Google Scholar 

  17. Goldberg LH, Kaplan B, Vergilis-Kalner I, Landau J. Liquid nitrogen: temperature control in the treatment of actinic keratosis. Dermatol Surg. 2010;36(12):1956–61.

    Article  PubMed  CAS  Google Scholar 

  18. Pyne J, Sapkota D, Wong JC. Cutaneous horns: clues to invasive squamous cell carcinoma being present in the horn base. Dermatol Pract Concept. 2013;3(2):3–7.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Yu RC, Pryce DW, Macfarlane AW, Stewart TW. A histopathological study of 643 cutaneous horns. Br J Dermatol. 1991;124(5):449–52.

    Article  PubMed  CAS  Google Scholar 

  20. Mantese SA, Diogo PM, Rocha A, Berbert AL, Ferreira AK, Ferreira TC. Cutaneous horn: a retrospective histopathological study of 222 cases. An Bras Dermatol. 2010;85(2):157–63.

    Article  PubMed  Google Scholar 

  21. Ceilley RI, Jorizzo JL. Current issues in the management of actinic keratosis. J Am Acad Dermatol. 2013;68(1 Suppl 1):S28–38.

    Article  PubMed  Google Scholar 

  22. Pasquali P. Photography in dermatology. In: Baldi A, Pasquali P, Spugnini EP (eds.) Skin cancer. A practical approach. Springer. Humana Press, New York; 2014:291–9.

    Google Scholar 

  23. Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison. Dermatol Surg. 2000;26(8):728–32.

    Article  PubMed  CAS  Google Scholar 

  24. Burkhart CG, Burkhart CN. Can cryosurgery in dermatology be augmented or assisted by pretreatment of skin? Int J Dermatol. 2008;47(10):1082–3.

    Article  PubMed  Google Scholar 

  25. Baust JG, Gage AA, Clarke D, Baust JM, Van Buskirk R. Cryosurgery–a putative approach to molecular-based optimization. Cryobiology. 2004;48(2):190–204.

    Article  PubMed  CAS  Google Scholar 

  26. Ondo AL, Padilla RS, Miedler JD, Cockerell CJ, Kerner JD, Steiner RL, Mings SM, Shanler SD. Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study. Dermatol Surg. 2012;38(9):1469–76.

    Article  PubMed  CAS  Google Scholar 

  27. Smit JV, de Sévaux RG, Blokx WA, van de Kerkhof PC, Hoitsma AJ, de Jong EM. Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: histologic and immunohistochemical effects. J Am Acad Dermatol. 2004;50(2):189–96.

    Article  PubMed  Google Scholar 

  28. Gold MH, Nestor MS. Current treatments of actinic keratosis. J Drugs Dermatol. 2006;5(2 Suppl):17–25.

    PubMed  Google Scholar 

  29. Hagele TJ, Levender MM, Davis SA, Williford PM, Feldman SR. Practice trends in the treatment of actinic keratosis in the United States: 0.5 % fluorouracil and combination cryotherapy plus fluorouracil are underused despite evidence of benefit. J Cutan Med Surg. 2012;16(2):107–14.

    PubMed  CAS  Google Scholar 

  30. Jorizzo J, Weiss J, Vamvakias G. One-week treatment with 0.5 % fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study. J Drugs Dermatol. 2006;5(2):133–9.

    PubMed  CAS  Google Scholar 

  31. Menter A, Vamvakias G, Jorizzo J. One-week treatment with once-daily in participants with actinic keratoses. Cutis. 2008;81(6):509–16.

    PubMed  Google Scholar 

  32. Jorizzo J. Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy? J Drugs Dermatol. 2004;3(1):21–6.

    PubMed  Google Scholar 

  33. Clarke DM, Robilotto AT, Rhee E, VanBuskirk RG, Baust JG, Gage AA, Baust JM. Cryoablation of renal cancer: variables involved in freezing-induced cell death. Technol Cancer Res Treat. 2007;6(2):69–79.

    PubMed  Google Scholar 

  34. Le Pivert PJ, Morrison DR, Haddad RS, Renard M, Aller A, Titus K, Doulat J. Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer. Technol Cancer Res Treat. 2009;8(3):207–16.

    PubMed  Google Scholar 

  35. Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology. 2004;49(1):45–61.

    Article  PubMed  CAS  Google Scholar 

  36. Jorizzo JL, Markowitz O, Lebwohl MG, Bourcier M, Kulp J, Meng TC, Levy S. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses. J Drugs Dermatol. 2010;9(9):110.

    Google Scholar 

  37. Quist SR, Gollnick HP. Imiquimod 3.75 % cream (Zyclara) for the treatment of actinic keratoses. Expert Opin Pharmacother. 2011;12(3):451–61.

    Article  PubMed  CAS  Google Scholar 

  38. Martin GM, Stockfleth E. Diclofenac sodium 3 % gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. J Drugs Dermatol. 2012;11(5):600–8.

    PubMed  CAS  Google Scholar 

  39. Mastrolonardo M. Topical diclofenac 3 % gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses. Clin Exp Dermatol. 2009;34(1):33–5.

    Article  PubMed  CAS  Google Scholar 

  40. Berlin JM, Rigel DS. Diclofenac sodium 3 % gel in the treatment of actinic keratoses postcryosurgery. J Drugs Dermatol. 2008;7(7):669–73.

    PubMed  Google Scholar 

  41. Berman B, Goldenberg G, Hanke W, Tyring SK, Werschler WP, Knudsen KM, Goncalves J, Larsson T, Skov T, Swanson N. Efficacy and safety of ingenol mebutate 0.015 % gel 3 weeks after cryosurgery of actinic keratosis: 11-week results. J Drugs Dermatol. 2014;13(2):154–60.

    PubMed  CAS  Google Scholar 

  42. Challacombe JM, Suhrbier A, Parsons PG, Jones B, Hampson P, Kavanagh D, Rainger GE, Morris M, Lord JM, Le TT, Hoang-Le D, Ogbourne SM. Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. J Immunol. 2006;177(11):8123–32.

    Article  PubMed  CAS  Google Scholar 

  43. Hampson P, Kavanagh D, Smith E, Wang K, Lord JM, Ed Rainger G. The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner. Cancer Immunol Immunother. 2008;57(8):1241–51.

    Article  PubMed  CAS  Google Scholar 

  44. Zide MF. Actinic keratosis: from the skin to the lip. J Oral Maxillofac Surg. 2008;66(6):1162–76.

    Article  PubMed  Google Scholar 

  45. Lubritz RR, Smolewski SA. Cryosurgery cure rate of premalignant leukoplakia of the lower lip. J Dermatol Surg Oncol. 1983;9(3):235–7.

    Article  PubMed  CAS  Google Scholar 

  46. Shah AY, Doherty SD, Rosen T. Actinic cheilitis: a treatment review. Int J Dermatol. 2010;49(11):1225–34.

    Article  PubMed  Google Scholar 

  47. Boy SC. Leukoplakia and erythroplakia of the oral mucosa–a brief overview. SADJ. 2012;67(10):558–60.

    PubMed  CAS  Google Scholar 

  48. Messadi DV. Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci. 2013;5(2):59–65.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia – a systematic review and meta-analysis. Head Neck. 2009;31(12):1600–9.

    Article  PubMed  Google Scholar 

  50. Yu CH, Lin HP, Cheng SJ, Sun A, Chen HM. Cryotherapy for oral precancers and cancers. J Formos Med Assoc. 2014;113(5):272–7.

    Google Scholar 

  51. Rigel DS, Stein LF. The importance of early diagnosis and treatment of actinic keratosis. J Am Acad Dermatol. 2013;68(1 Suppl 1):S20–7.

    Article  PubMed  Google Scholar 

  52. Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF, Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin in Chemoprevention Trial. Cancer. 2009;115(11):2523–30.

    Article  PubMed  Google Scholar 

  53. Zalaudek I, Piana S, Moscarella E, Longo C, Zendri E, Castagnetti F, Pellacani G, Lallas A, Argenziano G. Morphologic grading and treatment of facial actinic keratosis. Clin Dermatol. 2014;32(1):80–7.

    Article  PubMed  Google Scholar 

  54. Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;(12):CD004415.

    Google Scholar 

  55. Spencer J. Understanding actinic keratosis: epidemiology, biology, and management of the disease. J Am Acad Dermatol. 2013;68(1 Suppl 1):S1.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Pius Hospital de Valls, 43800, Tarragona, Spain

    Paola Pasquali MD

Authors
  1. Paola Pasquali MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paola Pasquali MD .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Pius Hospital de Valls, Valls, Tarragona, Spain

    Paola Pasquali

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pasquali, P. (2015). Premalignant Lesions: Combination Treatments in Cryosurgery. In: Pasquali, P. (eds) Cryosurgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43939-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43939-5_16

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43938-8

  • Online ISBN: 978-3-662-43939-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation